An update from Journey Medical Corp (DERM) is now available.
During the 2024 Annual Meeting, Journey Medical Corporation successfully passed three key proposals via a virtual platform with a strong stockholder turnout. Shareholders voted to elect five directors until the next annual meeting, ratified KPMG LLP as the independent accounting firm for the upcoming year, and approved an amendment to the company’s 2015 Stock Incentive Plan. The decisions, reflecting nearly 62% of eligible voting shares, underscore stockholder confidence and pave the way for the company’s strategic direction in the following year.
Find detailed analytics on DERM stock on TipRanks’ Stock Analysis page.
